Back to Search
ALAIN FABI, MD
MD
Neurological Surgery Physician
NPI: 1760462121IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
4301071650(MI)
CMS Specialties
PrimaryNEUROSURGERY
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 1992
Research & Publications (20)
Pseudoprogression and MGMT status in glioblastoma patients: implications in clinical practice.
PMID 19596935·Anticancer Res·2009
8-other
The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine.
PMID 19419544·J Exp Clin Cancer Res·2009
4-observational
Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation.
PMID 19335893·BMC Cancer·2009
8-other
Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study.
PMID 19415165·Neurol Sci·2009
8-other
Quantitative analysis of CT-perfusion parameters in the evaluation of brain gliomas and metastases.
PMID 19284885·J Exp Clin Cancer Res·2009
8-other
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study.
PMID 18771580·Breast Cancer Res·2008
4-observational
HER-2-positive metastatic breast cancer: trastuzumab and beyond.
PMID 18803447·Expert Opin Pharmacother·2008
6-review
Do HER-2 positive metastatic breast cancer patients benefit from the use of trastuzumab beyond disease progression? A mono-institutional experience and systematic review of observational studies.
PMID 18450443·Breast·2008
1-meta
Fixed dose-rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma: a dose-finding study.
PMID 17987263·J Neurooncol·2008
3-trial
Metastases to the cerebellum. Results and prognostic factors in a consecutive series of 44 operated patients.
PMID 18392776·J Neurooncol·2008
8-other
Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy.
PMID 18612799·J Neurooncol·2008
3-trial
Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha.
PMID 18375891·J Clin Oncol·2008
2-rct
Induction of ErbB-3 expression by alpha6beta4 integrin contributes to tamoxifen resistance in ERbeta1-negative breast carcinomas.
PMID 18270579·PLoS One·2008
8-other
Oral ondansetron is highly active as rescue antiemetic treatment for moderately emetogenic chemotherapy: results of a randomized phase II study.
PMID 18478278·Support Care Cancer·2008
3-trial
Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation.
PMID 18071704·Cancer Chemother Pharmacol·2008
3-trial
Clinical utility of continuing trastuzumab beyond brain progression in HER-2 positive metastatic breast cancer.
PMID 18165625·Oncologist·2007
8-other
Bone of the hands as unusual metastastatic site of renal cell carcinoma.
PMID 18365558·J Exp Clin Cancer Res·2007
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 601 JOHN ST, SUITE M 124
KALAMAZOO, MI 49007 - Phone
- (269) 341-7500
Quick Facts
- NPI
- 1760462121
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile